Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Recombinant Human TNF Receptor II Protein (6×His Tag) (AC1006)
Cat.#: ACPP-1006
Specifications
Despition Recombinant Human TNF Receptor II Protein (6×His Tag) for SDS-PAGE SIZE 50 µg Source Recombinant Protein Length Fragment Expression System HEK293 cells Protein Species Human Sequence TNFRSF1B (Leu23-Asp257) + 6×His Tag Molecular Weight 26.0 kDa without signal peptide Purity > 85% by SDS-PAGE and Coomassie blue staining. Form Lyophilized Tag C-terminal 6×His Tag Applications SDS-PAGE Storage Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1367 Myocilin Blocking Peptide (AC1367) 250 µg inquiry ACPP-1712 Human NME2 Protein (AC1712) 5 µg inquiry ACPP-1531 Human CHMP2B Protein (AC1531) 5 µg inquiry ACPP-1755 Human PDGFD Protein (AC1755) 5 µg inquiry ACPP-1309 CCR5 Blocking Peptide (AC1309) 250 µg inquiry ACPP-1500 Mouse PEBP1 Protein (AC1500) 5 µg inquiry ACPP-1026 Recombinant Human Neuropilin 1 Protein (6×His Tag) (AC1026) 50 µg inquiry ACPP-1625 Human POMC Protein (AC1625) 2 µg inquiry ACPP-1178 Recombinant Human CXCR4 Protein (Fc Tag) (AC1178) 50 µg inquiry ACPP-1788 Human NEUROG3 Protein (AC1788) 2 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket